Amwise is a series b startup based in China. 1 investor tracked. Status: zombie.
Based in China, Amwise is a startup. Its most recent tracked round is Series B. Brouky records 1 investor associated with the company.
Amwise is a Chinese biotechnology company focused on the research and development of innovative technologies for early cancer screening and diagnosis, primarily using DNA methylation detection.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.